Table 2.
Prediction of the functional consequences of the SNVs
| Type | Impact | Count | Fraction | Sum |
|---|---|---|---|---|
| Stop gained | High | 285 | 0.0% | 696 |
| Splice site donor | 209 | 0.0% | ||
| Splice site acceptor | 158 | 0.0% | ||
| Start lost | 26 | 0.0% | ||
| Stop lost | 18 | 0.0% | ||
| Non synonymous coding | Moderate | 26,239 | 0.3% | 26,239 |
| Synonymous coding | Low | 42,182 | 0.4% | 42,947 |
| Start gained | 725 | 0.0% | ||
| Synonymous stop | 35 | 0.0% | ||
| Non synonymous start | 5 | 0.0% | ||
| Intergenic | Modifier | 6,509,332 | 62.2% | 10,394,771 |
| Intron | 2,991,180 | 28.6% | ||
| Downstream | 430,875 | 4.1% | ||
| Upstream | 427,613 | 4.1% | ||
| UTR 3 Prime | 27,145 | 0.3% | ||
| UTR 5 Prime | 4,357 | 0.0% | ||
| Exon | 4,269 | 0.0% | ||
| Total effects | 10,464,653 | 10,464,653 |